A crossover study of short daily haemodialysis

Nephrology Dialysis Transplantation

Volumn 21, Issue 1, 2006, Pages 166-175

  Goldfarb Rumyantzev, Alexander S ^a,d   Leypoldt, John K ^a,b   Nelson, Natalia ^a   Kutner, Nancy G ^c   Cheung, Alfred K ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Blood pressure; Daily haemodialysis; Outcome; Quality of life; Quotidian haemodialysis; Urea kinetics

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BRAIN NATRIURETIC PEPTIDE; ERYTHROPOIETIN; HEMOGLOBIN; PHOSPHATE; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; FEMALE; HEALTH CARE PERSONNEL; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; MALE; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; VASCULAR ACCESS; WORKLOAD;

ADULT; AGED; BLOOD PRESSURE DETERMINATION; CROSS-OVER STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROBABILITY; PROGNOSIS; QUALITY OF LIFE; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UREA;

EID: 30344444769     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi116     Document Type: Article

References (21)

1. Woods JD, Port FK, Orzol S et al. Clinical and biochemical correlates of starting 'daily' hemodialysis. Kidney Int 1999; 55: 2467-2476
2. Ting G, Carrie B, Freitas T, Zarghamee S. Global ESRD costs associated with a short daily hemodialysis (sDHD) program in the U.S.A. Home Hemodial Int 1999; 3: 41-44
3. Klarenbach S, Heidenheim AP, Leitch R, Lindsay RM. Reduced requirement for erythropoietin with quotidian hemodialysis therapy. Asaio J 2002; 48: 57-61
4. Buoncristiani U, Fagugli R, Ciao G et al. Left ventricular hypertrophy in daily dialysis. Miner Electrolyte Metab 1999; 25: 90-94
5. Galland R, Traeger J, Arkouche W, Delawari E, Fouque D. Short daily hemodialysis and nutritional status. Am J Kidney Dis 2001; 37 [Suppl 2]: 95-98
6. Kutner NG. Quality of life and daily hemodialysis. Semin Dial 2004; 17: 92-98
7. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-310
8. Koshikawa S, Akizawa T, Saito A, Kurokawa K. Clinical effect of short daily in-center hemodialysis. Nephron Clin Pract 2003; 95: C23-c30
9. Williams AW, Chebrolu SB, Ing TS et al. Early clinical, quality-of-life, and biochemical changes of 'daily hemodialysis' (6 dialyses per week). Am J Kidney Dis 2004; 43: 90-102
10. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003; 42: 13-17
11. Lindsay RM, Leitch R, Heidenheim AP, Kortas C. The London daily/ nocturnal hemodialysis study-study design, morbidity, and mortality results. Am J Kidney Dis 2003; 42: 5-12
12. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994; 3: 329-338
13. Daugirdas JT. Second generation logarithmic estimate of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993; 4: 1025-1213
14. Leypoldt JK, Jaber BL, Zimmerman DL. Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 2004; 17: 142-145
15. Leypoldt JK, Cheung AK, Deeter RB. Single compartment models for evaluating beta 2-microglobulin clearance during hemodialysis. ASAIO J 1997; 43: 904-909
16. Andre MB, Rembold SM, Pereira CM, Lugon JR. Prospective evaluation of an in-center daily hemodialysis program: Results of two years of treatment. Am J Nephrol 2002; 22: 473-479
17. Suri R, Depner TA, Blake PG, Heidenheim AP, Lindsay RM. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003; 42: 42-48
18. Rao M, Muirhead N, Klarenbach S, Moist L, Lindsay RM. Management of anemia with quotidian hemodialysis. Am J Kidney Dis 2003; 42: 18-23
19. Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis 2003; 42: 30-35
20. Lindsay RM, Alhejaili F, Nesrallah G et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003; 42: 24-29
21. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994; 3: 329-338